Did you know that Arizona was the pioneer in establishing a dedicated statewide bioscience week. Arizona was unique in establishing its week early on, while most other states historically relied on single-day summits or standalone conferences. The structured, multi-day format has gained major traction over the last decade in other states or regions.Continue reading
Category Archives: AZBio News
SuperAging is not simply the opposite of Alzheimer’s disease
A new study reveals that exceptional memory aging cannot be explained simply by low inherited Alzheimer’s disease risk, reinforcing the importance of studying protective pathways directlContinue reading
AZBio Member Spotlight- Darwin Research Group
Based in Scottsdale, Arizona, Darwin Research Group has spent over a decade producing primary intelligence that helps life sciences companies navigate one of the most consequential shifts in modern healthcare: the rise of organized systems of care.Continue reading
LaunchAZ Fall Cohort – Bioscience and Healthcare
Up to 15 companies will be selected from the applicant pool to take part in each cohort anchored around key activities in the state. The Fall 2026 Cohort will focus on biotech and health tech and will coincide with Arizona Bioscience Week, kicking off on October 5, 2026. Applications close August 7, 2026.Continue reading
Feedback Sought on Proposals to Reform Pharmaceutical Pricing, Bolster Innovation
On June 16, 2026, Senate Finance Committee Ranking Member Ron Wyden (D-OR) released a request for information on a host of proposals aimed at lowering the cost of prescription drugs, as a part of Senate Democrats’ work to make health care affordable for all Americans. Text of the Request for Information (PDF) Members of the public are encouraged to weigh in with feedback by August 17, 2026.
The request for information focuses on three policy objectives:
- Lowering the price manufacturers charge for prescription drugs
- Lowering out-of-pocket costs for patients
- Fostering biopharmaceutical innovation in areas of unmet need, bolstering domestic clinical trials, and recruiting and maintaining scientific talent
Crown Bioscience Joins C-Path’s New Approach Methodologies Developer Coalition
Global contract research organization specializing in translational oncology brings its preclinical model and biomarker capabilities to the coalition’s work advancing the adoption and qualification of new approach methodologies.Continue reading
NuvOx Therapeutics Receives FDA Fast Track Designation to NanO₂™ for the Treatment of Acute Ischemic Stroke
TUCSON, AZ, July 15, 2026 — NuvOx Therapeutics, Inc. (“NuvOx Therapeutics”, “NuvOx”, or the “Company”) today announces that its wholly owned subsidiary, NuvOx Pharma LLC, has been granted Fast Track designation for NanO₂™ by the U.S. Food and Drug Administration (“FDA”) for the treatment of adult patients presenting with acute ischemic stroke (“AIS”).
Karen Bernstein, One of Biotech’s Most Influential Voices, Elected C-Path Board Chair
BioCentury co-founder succeeds Wain Fishburn, effective July 1Continue reading
TGen scientists identify nanobody that can be engineered to clear Alzheimer’s plaques
Fusion antibody was comparable to aducanumab treatment in clearing amyloid plaques in mice